Date published: 2025-11-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

PHRF1 Inhibitors

PHRF1 inhibitors constitute a distinct class of chemical compounds designed to modulate the activity of the Plant Homeodomain Finger Protein 1 (PHRF1). This class of inhibitors operates at the molecular level, targeting PHRF1's enzymatic function and its interactions with other cellular components. PHRF1, a protein recognized for its involvement in various biological processes including transcriptional regulation, cell cycle control, and DNA repair, possesses a unique catalytic domain susceptible to manipulation by these inhibitors. The chemical structures of PHRF1 inhibitors are characterized by their ability to specifically interact with key regions of PHRF1's catalytic domain, disrupting its normal functionality. These inhibitors often feature intricate arrangements of atoms and functional groups that allow for binding to specific pockets or active sites within the protein's structure. Their mode of action involves altering the conformational dynamics of PHRF1, ultimately leading to the interference of its enzymatic activity.

The rationale behind designing and synthesizing PHRF1 inhibitors hinges on the fundamental understanding of the protein's biological significance. Researchers endeavor to decipher the intricate mechanisms by which PHRF1 contributes to cellular processes, and subsequently, design inhibitors that perturb these processes for experimental investigation. Chemical modifications and rational design approaches are employed to fine-tune the inhibitory effects of these compounds, thereby enabling researchers to dissect PHRF1's precise role in various cellular contexts. The development of PHRF1 inhibitors requires a profound understanding of the protein's structure and function. Utilizing techniques such as X-ray crystallography and computational modeling, researchers gain insights into the three-dimensional architecture of PHRF1, allowing them to identify potential binding sites for inhibitors.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

GSK343

1346704-33-3sc-397025
sc-397025A
5 mg
25 mg
$148.00
$452.00
1
(0)

An inhibitor that specifically targets the catalytic activity of PHRFIt has been shown to reduce the growth of certain cancer cells by disrupting the function of PHRF1 in transcriptional regulation.

MS023

1831110-54-3sc-507463
5 mg
$165.00
(0)

This compound is known to inhibit the PHRF1 protein by interfering with its binding to specific substrates. It has demonstrated potential in suppressing cancer cell growth and promoting cell death.

GSK126

1346574-57-9sc-490133
sc-490133A
sc-490133B
1 mg
5 mg
10 mg
$90.00
$238.00
$300.00
(0)

While primarily recognized as an EZH2 inhibitor, GSK126 also affects PHRF1 by modulating its enzymatic activity.